Cortical Neurons In Frontotemporal Dementia is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.
Frontotemporal dementia (FTD) is a heterogeneous group of neurodegenerative disorders characterized by progressive atrophy of the frontal and temporal lobes. Cortical neurons in these regions are particularly vulnerable to degeneration in FTD, leading to the characteristic changes in personality, behavior, and language. [1]
The study of Cortical Neurons In Frontotemporal Dementia has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development. [2]
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. [3]
Additional evidence sources: [4] [5] [6] [7]
Seelaar H, et al. Clinical, pathological and genetic heterogeneity of frontotemporal dementia. Brain. 2011. ↩︎
Neumann M, et al. TDP-43 pathology in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. J Mol Neurosci. 2011. ↩︎
Goedert M, et al. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Cold Spring Harb Perspect Med. 2017. ↩︎
Boxer AL, et al. Frontotemporal dementia: update on emerging diagnostic and therapeutic strategies. J Geriatr Psychiatry Neurol. 2013. ↩︎
Rohrer JD, et al. The clinical and neuroanatomical profile of frontotemporal dementia linked to chromosome 3. Brain. 2011. ↩︎
Snowden JS, et al. Cognitive phenotypes in progressive aphasia. Brain. 2011. ↩︎
Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem. 2016. ↩︎